Haoxi Health Technology Ltd. reported revenue of $32.80 million for the fiscal year ended June 30, 2025, compared to $48.52 million for the same period in 2024, representing a decrease of $15.71 million or 32%. Cost of revenue was $31.88 million in 2025, down from $45.77 million in 2024. Net income for the fiscal year 2025 was $3.88 million, up from $1.29 million in 2024, an increase of approximately $2.58 million.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Haoxi Health Technology Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-100369), on October 20, 2025, and is solely responsible for the information contained therein.
Comments